2-AG |
2-arachidonoylglycerol |
AEA
|
N-arachidonoyl ethanolamide |
CB1R |
Cannabinoid receptor type 1 |
CB2R |
Cannabinoid receptor type 2 |
FDA |
Food & Drug Administration |
NSAIDs |
Nonsteroidal anti-inflammatory drugs |
Δ9-THC |
Δ9-Tetrahydrocannabinol |
Δ9-THCA |
Δ9-tetrahydrocannabinolic acid |
Δ9-THCV |
Δ9-tetrahydrocannabivarin |
AM251 |
N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide |
AM281 |
N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide |
AM630 |
6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone |
AM1241 |
(2-iodo-5-nitrophenyl)-[1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl]-methanone |
AT
|
Anandamide transporter |
ACPA |
Arachidonylcyclopropylamide |
Aβ |
Beta-amyloid |
CB
|
Cannabinoid |
CBD
|
Cannabidiol |
CBDL |
Cannabinodiol |
CBC
|
Cannabichromene |
CBCV |
Cannabichromevarin |
CBL
|
Cannabicyclol |
CBE
|
Cannabielson |
CBG
|
Cannabigerol |
CBGV |
Cannabigerovarin |
CBGM |
Cannabigerol Monoethyl Ether |
CBN
|
Cannabinol |
CBT
|
Cannabitriol |
CBV
|
Cannabivarin |
COX2
|
cyclooxygenase subtype 2 |
CP55940 |
(−)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol |
ERK
|
Extracellular-regulated kinase |
FAAH
|
Fatty acid amide hydrolase |
GI
|
Gastrointestinal |
GCPR
|
G-Coupled Protein Receptor |
HU-210 |
(6aR)-trans-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol |
JWH-015 |
(2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone |
JWH-133 |
3-(1,1-dimethylbutyl)-6,6,9-trimethyl-6α,7,10,10α-tetrahydro-6H-benzo[c]chromene |
PPARγ
|
Peroxisome proliferator-activated receptor γ |
TRVP1 |
Transient receptor potential vanilloid type 1 |
MAP
|
Mitogen-activated protein kinase |
R-(+)-WIN55212
|
(R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone |
SR141716A |
N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride |
SR144528 |
N-[(1S)-endo-1,3,3-trimethyl bicyclo [2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide |
DAGL |
Diacylglycerol lipase |
MAGL |
Monoacylglycerol lipase |
NAPE-PLD |
N-acetyl-phosphatidyl-ethanolamine-hydrolyzing phospholipase D |
PEA |
Palmitoylethanolamide |
OEA |
Oleoylethanolamine |
FAAH |
Fatty acid amide hydrolase |
NAAH |
N-acylethanolamine acid amide hydrolase |
ABHD6 |
Alpha/beta-Hydrolase domain containing 6 |
ABHD12 |
Alpha/beta-Hydrolase domain containing 12 |
GABA |
Gamma aminobutyric acid |
GPR55 |
G-protein coupled receptor 55 |
GPR18 |
G-protein coupled receptor 18 |
GPR119 |
G-protein coupled receptor 119 |
FABS |
Fatty Acid Binding Protein |
HSP70s |
70 kilodalton heat shock proteins |
AMT |
Anandamide membrane transporter |
EMT |
Endocannabinoid membrane transporter |